MX9100246A - Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion - Google Patents

Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion

Info

Publication number: MX9100246A
Authority: MX; Mexico
Prior art keywords: preparation; tablets; sulcralphate; procedure; sugar
Prior art date: 1990-07-19

Application number

MX9100246A

Other languages

English (en)

Inventor

Hans Peter Weckenmann

Hans-Gunther Schwamb

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-19

Filing date

1991-07-17

Publication date

1992-02-28

1991-07-17 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1992-02-28 Publication of MX9100246A publication Critical patent/MX9100246A/es

Links

239000008298 dragée Substances 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
235000003599 food sweetener Nutrition 0.000 abstract 2
239000003765 sweetening agent Substances 0.000 abstract 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
229930195725 Mannitol Natural products 0.000 abstract 1
230000001055 chewing effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
239000000594 mannitol Substances 0.000 abstract 1
235000010355 mannitol Nutrition 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
235000015424 sodium Nutrition 0.000 abstract 1
239000000600 sorbitol Substances 0.000 abstract 1
239000000230 xanthan gum Substances 0.000 abstract 1
229920001285 xanthan gum Polymers 0.000 abstract 1
229940082509 xanthan gum Drugs 0.000 abstract 1
235000010493 xanthan gum Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Confectionery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

MX9100246A 1990-07-19 1991-07-17 Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion MX9100246A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4022944A DE4022944A1 (de)	1990-07-19	1990-07-19	Sucralfat-kautablette

Publications (1)

Publication Number	Publication Date
MX9100246A true MX9100246A (es)	1992-02-28

Family

ID=6410578

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9100246A MX9100246A (es)	1990-07-19	1991-07-17	Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion

Country Status (20)

Country	Link
US (1)	US5648092A (es)
EP (1)	EP0471967B1 (es)
JP (1)	JPH04234324A (es)
KR (1)	KR0181955B1 (es)
AT (1)	ATE137117T1 (es)
AU (1)	AU646474B2 (es)
CA (1)	CA2046843A1 (es)
CZ (1)	CZ280566B6 (es)
DE (2)	DE4022944A1 (es)
DK (1)	DK0471967T3 (es)
ES (1)	ES2088445T3 (es)
FI (1)	FI98702C (es)
GR (1)	GR3020228T3 (es)
HU (1)	HU208488B (es)
IE (1)	IE73252B1 (es)
MX (1)	MX9100246A (es)
PT (1)	PT98311B (es)
SK (1)	SK279206B6 (es)
TW (1)	TW198691B (es)
ZA (1)	ZA915698B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1081921C (zh) *	1994-04-26	2002-04-03	中外制药株式会社	硫糖铝的熔融造粒制剂及其制造方法
WO1996023507A1 (en) *	1995-02-02	1996-08-08	Chugai Seiyaku Kabushiki Kaisha	Sucralfate preparation
TW469135B (en) *	1995-10-03	2001-12-21	Chugai Pharmaceutical Co Ltd	Chewable tablet
CA2262595C (en) *	1996-08-15	2005-10-18	Losan Pharma Gmbh	Easy to swallow oral medicament composition
ATE288742T1 (de) *	1997-07-10	2005-02-15	Gergely Dr & Co	Lösliche, gummihaltige, dragierte kautablette
DE19758100B4 (de) *	1997-12-18	2006-05-04	Lichtwer Pharma Ag	Verfahren zum Herstellen von Pflanzenextrakt enthaltenden pharmazeutischen Formulierungen
WO1999033445A1 (en) *	1997-12-29	1999-07-08	The Procter & Gamble Company	Tablet composition
US6197329B1 (en)	1999-05-03	2001-03-06	Drugtech Corporation	Anti-nausea compositions and methods
AU5086799A (en) *	1999-06-30	2001-01-22	Procter & Gamble Company, The	Personal hygiene tablet composition
US20040013732A1 (en) *	2001-09-25	2004-01-22	Michael Farber	Starch-based delivery system for creatine
US7067150B2 (en) *	2002-04-16	2006-06-27	Scepter Holdings, Inc.	Delivery systems for functional ingredients
AUPS244002A0 (en)	2002-05-20	2002-06-13	John Kohnke Products Pty Ltd	Agent delivery system
US20080160086A1 (en) *	2004-02-19	2008-07-03	Scepter Holdings, Inc.	Delivery Systems For Calcium
US9028882B2 (en) *	2005-05-02	2015-05-12	4Life Patents, Llc	Nutraceutical gels
CN101198340B (zh) *	2005-05-02	2014-07-09	福莱专利有限责任公司	转移因子制品及相关的方法
FR2927808B1 (fr) *	2008-02-26	2011-04-29	Fabre Pierre Dermo Cosmetique	Gel de sucralfate sterilise
KR102329377B1 (ko) *	2017-02-03	2021-11-19	가부시키가이샤 도요 신야쿠	고형 제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4983392A (en) *	1983-11-14	1991-01-08	Bio-Mimetics, Inc.	Bioadhesive compositions and methods of treatment therewith
DE3430809A1 (de) *	1984-08-22	1986-03-06	Merck Patent Gmbh, 6100 Darmstadt	Sucralfat-suspension
US4684534A (en) *	1985-02-19	1987-08-04	Dynagram Corporation Of America	Quick-liquifying, chewable tablet
DK505588D0 (da) *	1988-02-26	1988-09-09	Jesper Hamburger	Middel og anvendelse af samme
IT1219942B (it) *	1988-05-13	1990-05-24	Fidia Farmaceutici	Esteri polisaccaridici
US4910023A (en) *	1988-06-09	1990-03-20	Warner-Lambert Company	Drug in combination with flavor masking agent and method for making same
US4990610A (en) *	1988-08-25	1991-02-05	Applied Analytical Industries, Inc.	Method for preparing high potency sucralfate
US4975281A (en) *	1989-01-30	1990-12-04	E. R. Squibb & Sons, Inc.	Anti-ulcer composition
US5013557A (en) *	1989-10-03	1991-05-07	Warner-Lambert Company	Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same

1990
- 1990-07-19 DE DE4022944A patent/DE4022944A1/de not_active Withdrawn
1991
- 1991-07-08 EP EP91111305A patent/EP0471967B1/de not_active Expired - Lifetime
- 1991-07-08 AT AT91111305T patent/ATE137117T1/de not_active IP Right Cessation
- 1991-07-08 DK DK91111305.8T patent/DK0471967T3/da active
- 1991-07-08 DE DE59107709T patent/DE59107709D1/de not_active Expired - Fee Related
- 1991-07-08 ES ES91111305T patent/ES2088445T3/es not_active Expired - Lifetime
- 1991-07-11 JP JP3196055A patent/JPH04234324A/ja active Pending
- 1991-07-12 PT PT98311A patent/PT98311B/pt not_active IP Right Cessation
- 1991-07-16 AU AU80462/91A patent/AU646474B2/en not_active Ceased
- 1991-07-17 MX MX9100246A patent/MX9100246A/es active IP Right Grant
- 1991-07-17 TW TW080105557A patent/TW198691B/zh active
- 1991-07-17 CA CA002046843A patent/CA2046843A1/en not_active Abandoned
- 1991-07-18 CZ CS912241A patent/CZ280566B6/cs not_active IP Right Cessation
- 1991-07-18 KR KR1019910012252A patent/KR0181955B1/ko not_active Expired - Fee Related
- 1991-07-18 SK SK2241-91A patent/SK279206B6/sk unknown
- 1991-07-18 FI FI913479A patent/FI98702C/fi active IP Right Grant
- 1991-07-18 IE IE253191A patent/IE73252B1/en not_active IP Right Cessation
- 1991-07-19 US US07/732,523 patent/US5648092A/en not_active Expired - Fee Related
- 1991-07-19 HU HU912431A patent/HU208488B/hu not_active IP Right Cessation
- 1991-07-19 ZA ZA915698A patent/ZA915698B/xx unknown
1996
- 1996-06-13 GR GR960401598T patent/GR3020228T3/el unknown

Also Published As

Publication number	Publication date
KR920002155A (ko)	1992-02-28
KR0181955B1 (ko)	1999-05-01
FI913479A0 (fi)	1991-07-18
AU8046291A (en)	1992-01-23
IE912531A1 (en)	1992-01-29
HU208488B (en)	1993-11-29
PT98311B (pt)	1999-01-29
HUT63056A (en)	1993-07-28
FI98702B (fi)	1997-04-30
ZA915698B (en)	1992-05-27
EP0471967A1 (de)	1992-02-26
FI913479L (fi)	1992-01-20
DE59107709D1 (de)	1996-05-30
CA2046843A1 (en)	1992-01-20
ES2088445T3 (es)	1996-08-16
US5648092A (en)	1997-07-15
ATE137117T1 (de)	1996-05-15
DE4022944A1 (de)	1992-01-23
FI98702C (fi)	1997-08-11
IE73252B1 (en)	1997-05-21
JPH04234324A (ja)	1992-08-24
EP0471967B1 (de)	1996-04-24
SK279206B6 (sk)	1998-08-05
AU646474B2 (en)	1994-02-24
CS224191A3 (en)	1992-02-19
HU912431D0 (en)	1991-12-30
TW198691B (es)	1993-01-21
PT98311A (pt)	1992-05-29
CZ280566B6 (cs)	1996-02-14
DK0471967T3 (da)	1996-08-05
GR3020228T3 (en)	1996-09-30

Legal Events

Date	Code	Title	Description
1997-08-07	FG	Grant or registration

Publication	Publication Date	Title
MX9100246A (es)	1992-02-28	Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
ES2040232T3 (es)	1993-10-16	Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ES8801766A1 (es)	1987-08-01	Procedimiento de obtencion de un sistema de suministro de ingredientes activos
AR015598A1 (es)	2001-05-16	FORMULACIoN LIOFILIZADA QUE COMPRENDE PROTEíNA C ACTIVADA, SU USO PARA LA PREPARACIoN DE UN MEDICAMENTO Y FORMA DE DOSIS UNITARIA QUE LA COMPRENDE.
SE8702940D0 (sv)	1987-07-23	Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
MX10086A (es)	1993-12-01	Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
IT1205031B (it)	1989-03-10	Derivati dell' etere immidazochinolinilico ad azione farmaceutica e procedimento per la loro preparazione
DE69735644D1 (de)	2006-05-18	Nateglinide zubereitung in tablettenform
FI945081A0 (fi)	1994-10-28	Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
IT1217445B (it)	1990-03-22	Composizione farmaceutiche orosolubili contenti acetilcisteina
SE8702941L (sv)	1988-01-25	Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
SE8704952L (sv)	1988-06-13	Farmaceutisk komposition
PH27446A (en)	1993-07-02	Compound with gastric acid inhibitory effect
IT8219482A0 (it)	1982-02-05	Composizione farmaceutica per la cura di affezioni della cavita'orale.
SE8703632D0 (sv)	1987-09-21	Sustained release fluoride composition
ES2076543T3 (es)	1995-11-01	Extracto de kawa-kawa, procedimiento para su preparacion y su utilizacion.
ES2054188T3 (es)	1994-08-01	Medicamento masticable o chupable, procedimiento para su produccion y aplicacion.
IT8621097A1 (it)	1988-01-10	Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
IT1277348B1 (it)	1997-11-10	Composizione farmaceutica per abbassare la pressione del sangue e procedimento per la sua preparazione
ATE227519T1 (de)	2002-11-15	Kalziumreiche gelierte paste ohne zucker
ES2059683T3 (es)	1994-11-16	Composiciones farmaceuticas microencapsuladas con separacion de fases, perfeccionadas, utiles para aliviar enfermedades dentales.
ES2103682B1 (es)	1998-04-01	Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas.
DK493887A (da)	1987-09-21	Buccal formulering
AT389114B (de)	1989-10-25	7-acyloxy-6-aminoacyloxypolyoxylabdane und verfahren zu ihrer herstellung
SG12284G (en)	1985-01-04	Pharmaceutical preparation for administration to the mucosa of the oral or nasal cavity